Advocacy intelligence hub — real-time data for patient organizations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — PHASE2
Crinetics Pharmaceuticals Inc. — PHASE1, PHASE2
Post Graduate Institute of Medical Education and Research, Chandigarh
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Acthrel
(Corticorelin ovine triflutate)Orphan drugstandardFerring Laboratories, Inc.
Orlaam
(Levomethadyl acetate hydrochloride)Orphan drugstandardBiodevelopment Corporation
Lynnette K Nieman, M.D., M.D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 BETHESDA, MD
Frank Czerwiec, MD, MD, PhD
Sparrow Pharmaceuticals (info@sparrowpharma.com)
📍 ROCKVILLE, MD
Andreas Moraitis, M.D., M.D
Corcept Therapeutics
📍 SUNNY ISLES BEACH, FL